Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

• Status: Terminated
• Trial end date: 2010-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to demonstrate that dutogliptin/PHX1149T is safe and tolerable.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Phenomix

Criteria

Inclusion Criteria:

• Completed Visit 7/Day 98 of the core protocol PHX1149-PROT202

• Current treatment of Type 2 diabetes mellitus in accordance with product labeling with metformin, or thiazolidinedione (TZD), or metformin + TZD

Exclusion Criteria:

• Inadequately controlled Type 2 diabetes mellitus with need for therapy with insulin